Semaglutide 8mg Injection Pen Kit

Name: Semaglutide | Premium UK Supply
Price: 149.99 GBP
Availability: InStock

£149.99

The Synedica Semaglutide® Injection Pen Kit is a clinically advanced treatment for weight loss. Known commonly as Ozempic, semaglutide works by mimicking the natural hormone GLP-1, which signals to your brain that you are full after eating. By reducing appetite and cravings, it supports significant and sustainable weight loss.

What does the 1mg Kit Contain?

2 × Synedica semaglutide pens (each containing 4mg)
12 × disposable 32g 4mm needles
1 × instruction booklet

Each pen delivers up to 4 full doses of 1mg or smaller increments of 0.25mg, 0.5mg, 0.75mg, or 1mg, depending on your prescribed dosage.

Recommended Dosage Schedule:

Weeks 1–4: 0.25mg once weekly
Weeks 5–8: 0.5mg once weekly
After 8 weeks: Your doctor may increase to 0.75mg or 1mg once weekly

Category: Injectable Steriods

Description

Buy Semaglutide UK

What is the Synedica Semaglutide® Injection Pen Kit?
The Synedica Semaglutide® Injection Pen Kit is one of the world’s most advanced medical weight loss solutions. Containing semaglutide (commonly known as Ozempic), it works by mimicking the hormone GLP-1 to suppress appetite, helping you feel fuller after smaller meals. A single kit typically lasts 12 weeks for new users.

Key Benefits:

Reduces appetite and cravings throughout the day
Supports significant and sustainable fat loss
Helps avoid the hunger pangs of traditional dieting

Common Side Effects:
Mild to moderate side effects may include nausea, jaw ache, and low mood. A complete list of potential side effects can be found in the included patient information booklet.

What’s Included in Each Kit:

2 × Synedica semaglutide pens
12 × disposable 32g 4mm needles
1 × instruction booklet

Cost & Availability:

Typical cost: €300 per kit (12 weeks supply) from private pharmacies
May be covered by employer health policies or available to eligible patients in Germany through Gesetzliche Krankenversicherung (GKV)
Currently available by prescription only in Germany

Synedica vs Other GLP-1 Medications:

Semaglutide (Synedica/Ozempic): First-line treatment, targeting 1 receptor (GLP-1)
Tirzepatide: Second-line option for patients with semaglutide tolerance; targets 2 receptors for greater effect at lower doses
Retatrutide: Newest triple-agonist, targeting 3 receptors, ideal for patients who have developed tolerance to tirzepatide

UK Supply & Compliance: Secure packaging, clear labeling, and discreet UK dispatch options support repeat purchasing workflows.